Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

545
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
545
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.2K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.2K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

13.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
13.6K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.1K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.1K
Standard Precaution01:26

Standard Precaution

2.3K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.3K
Hand hygiene01:23

Hand hygiene

4.4K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of Allplex HPV HR Detection Full Genotyping Assay on Cervical Samples Compared to Vaginal Self-Samples.

Journal of medical virology·2026
Same author

Clinical Validation of Four Point-of-Care High-Risk HPV Assays, Including Two Reduced-Valency Assays, for Cervical Cancer Screening in Low-Resource Settings.

International journal of cancer·2026
Same author

Resilience to HPV vaccine safety scares in seven countries.

Journal of global health·2026
Same author

Evaluating DNA methylation markers and extended HPV genotyping in first-void urine for detecting high-grade cervical lesions in HPV-positive women: a cross-sectional study.

BMC medicine·2026
Same author

Clinical performance of ASCL1/LHX8 DNA methylation on first-void urine to screen for cervical cancer.

Communications medicine·2026
Same author

Barriers to and facilitators of cancer prevention services for transgender and gender-diverse people: A systematic review.

Preventive medicine·2026

Related Experiment Video

Updated: Oct 5, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.7K

HPV prevention and control - The way forward.

Alex Vorsters1, F Xavier Bosch2, Mario Poljak3

  • 1Center for the Evaluation of Vaccination & HPV Prevention and Control Board, University of Antwerp, Antwerp, Belgium.

Preventive Medicine
|January 23, 2022
PubMed
Summary

The COVID-19 pandemic offers a chance to repurpose healthcare resources for human papillomavirus (HPV) prevention. Lessons learned from COVID-19 vaccination and testing can help eradicate HPV-induced cancers.

Keywords:
COVID-19 pandemicCervical cancerEliminationHPVPrevention and controlScreeningTreatmentVaccination

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.6K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.6K

Related Experiment Videos

Last Updated: Oct 5, 2025

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.7K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

27.6K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.6K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Oncology

Background:

  • The COVID-19 pandemic has significantly expanded healthcare infrastructure for vaccination, testing, and public education.
  • Human papillomavirus (HPV) is a common sexually transmitted infection and a leading cause of various cancers, including cervical, head and neck, and anal cancers.
  • Cervical cancer elimination is a global goal, emphasizing adolescent vaccination, widespread screening, and treatment of infected women.

Purpose of the Study:

  • To highlight the opportunity to leverage COVID-19 resources for HPV prevention and control.
  • To summarize available tools for HPV control.
  • To discuss public health threats during the ongoing COVID-19 pandemic.

Main Methods:

  • This commentary synthesizes information from the COVID-19 response.
  • It reviews existing strategies and tools for HPV prevention and control.
  • It analyzes the potential application of pandemic-generated resources to HPV eradication efforts.

Main Results:

  • The pandemic has created valuable logistical, technical, and human resources applicable to other infectious diseases.
  • Existing tools for HPV prevention include vaccination and screening programs.
  • Sustaining and redeploying these resources is crucial for combating HPV-induced cancers.

Conclusions:

  • The infrastructure and experience gained from the COVID-19 response can be strategically applied to enhance human papillomavirus (HPV) prevention and control programs.
  • Effective utilization of these resources presents a critical opportunity to advance global goals for HPV-related cancer elimination.
  • Continued vigilance and resource allocation are necessary to address the ongoing public health impact of HPV infections.